Literature DB >> 15920569

Assessment of visual function in chronic progressive external ophthalmoplegia.

C Y Yu Wai Man1, T Smith, P F Chinnery, D M Turnbull, P G Griffiths.   

Abstract

AIMS: To assess the visual function of patients with chronic progressive external ophthalmoplegia (CPEO) using the Visual Function Index (VF-14). To identify discriminatory questions that reflect visual disability in mitochondrial ocular myopathies. To investigate the relationship between visual impairment and the ocular parameters routinely measured in clinical practice.
METHODS: We studied 40 CPEO patients. Each patient underwent ophthalmological assessment, including best-corrected visual acuity, ptosis measures, and fundus examination for pigmentary retinopathy, and orthoptic assessment including cover test in the primary position, assessment of diplopia, and measurement of uniocular fields of fixation using the Goldmann perimeter. Patients were interviewed by telephone by an independent observer and their visual function was assessed using the VF-14.
RESULTS: A total of 38 patients (95%) were visually impaired. The mean VF-14 was 72 (95% CI 66-79). Patients reported having the most difficulty with reading small print and driving at night. No significant correlation was found between the VF-14 and ocular motility parameters, ptosis, or pigmentary retinopathy.
CONCLUSIONS: CPEO is associated with significant visual impairment. Measures of visual disability should be included in studies of natural history and treatment of mitochondrial ocular myopathies.

Entities:  

Mesh:

Year:  2006        PMID: 15920569     DOI: 10.1038/sj.eye.6701924

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  7 in total

1.  Progressive external ophthalmoplegia (PEO) due to a mutation in the C10orf2 (PEO1) gene mimicking a myasthenic crisis.

Authors:  Dolores Gonzalez-Moron; Jose Bueri; Marcelo Andres Kauffman
Journal:  BMJ Case Rep       Date:  2013-09-07

Review 2.  How can we treat mitochondrial encephalomyopathies? Approaches to therapy.

Authors:  Rita Horvath; Grainne Gorman; Patrick F Chinnery
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

Review 3.  Progressive External Ophthalmoplegia.

Authors:  Collin McClelland; Georgios Manousakis; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

4.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

Review 5.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

Review 6.  Mitochondrial Disorders.

Authors:  Thomas Klopstock; Claudia Priglinger; Ali Yilmaz; Cornelia Kornblum; Felix Distelmaier; Holger Prokisch
Journal:  Dtsch Arztebl Int       Date:  2021-11-05       Impact factor: 8.251

7.  Extraocular muscle atrophy and central nervous system involvement in chronic progressive external ophthalmoplegia.

Authors:  Cynthia Yu-Wai-Man; Fiona E Smith; Michael J Firbank; Grant Guthrie; Stuart Guthrie; Grainne S Gorman; Robert W Taylor; Douglass M Turnbull; Philip G Griffiths; Andrew M Blamire; Patrick F Chinnery; Patrick Yu-Wai-Man
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.